000			01484 a2200457 4500
005			20250513130826.0
264		0	_c19971212
008			199712s 0 0 eng d
022			_a0967-0149
040			_aNLM _beng _cNLM
100	1		_aWing, M G
245	0	0	_aEx-vivo whole blood cultures for predicting cytokine-release syndrome: dependence on target antigen and antibody isotype. _h[electronic resource]
260			_bTherapeutic immunology _cAug 1995
300			_a183-90 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlemtuzumab
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibodies, Neoplasm _ximmunology
650	0	4	_aAntigens, CD _ximmunology
650	0	4	_aAntigens, Neoplasm
650	0	4	_aArthritis, Rheumatoid _xblood
650	0	4	_aBlood Cells _xdrug effects
650	0	4	_aCD52 Antigen
650	0	4	_aFemale
650	0	4	_aGlycoproteins
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _ximmunology
650	0	4	_aLipopolysaccharides
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymyxin B _xpharmacology
650	0	4	_aTumor Necrosis Factor-alpha _xanalysis
700	1		_aWaldmann, H
700	1		_aIsaacs, J
700	1		_aCompston, D A
700	1		_aHale, G
773	0		_tTherapeutic immunology _gvol. 2 _gno. 4 _gp. 183-90
999			_c9328858 _d9328858